67 Hong Kong Pharmaceuticals & Biotech Stocks - Strong Balance Sheet Stocks - Investing Ideas

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
2315 Biocytogen Pharmaceuticals (Beijing)	HK$7.80	17.1%	-68.7%	HK$3.1b	HK$15.39	PS4x	E100.1%	n/a
2509 Qyuns Therapeutics	HK$23.85	4.4%	n/a	HK$4.9b	n/a	PS357x	n/a	n/a
1477 Ocumension Therapeutics	HK$5.84	0%	-36.2%	HK$4.1b	HK$8.41	PS15.2x	E93.7%	n/a
6998 Genor Biopharma Holdings	HK$1.16	1.8%	-41.7%	HK$590.1m	n/a	PB0.5x	n/a	n/a
1875 TOT BIOPHARM International	HK$1.54	-1.3%	-30.0%	HK$1.2b	HK$3.80	PS1.4x	n/a	n/a
2181 Mabpharm	HK$0.42	-6.6%	-31.5%	HK$1.8b	n/a	PS18.6x	n/a	n/a
6855 Ascentage Pharma Group International	HK$16.58	-2.1%	-29.9%	HK$4.7b	HK$29.58	PS19.6x	E20.9%	n/a
1558 YiChang HEC ChangJiang Pharmaceutical	HK$11.96	-6.0%	67.0%	HK$10.5b	HK$14.00	PE4.9x	S2.2%	0%
2137 Brii Biosciences	HK$1.01	8.6%	-77.3%	HK$736.9m	HK$4.66	PS12.2x	E15.9%	n/a
9995 RemeGen	HK$28.35	-2.9%	-42.1%	HK$24.2b	HK$43.24	PS13x	E50.8%	n/a
2126 JW (Cayman) Therapeutics	HK$1.72	-3.4%	-51.1%	HK$694.1m	HK$2.72	PS3.7x	E28.3%	n/a
9939 Kintor Pharmaceutical	HK$1.02	15.9%	-82.1%	HK$456.4m	HK$14.51	PB0.9x	E27.0%	n/a
1312 Kontafarma China Holdings	HK$0.036	9.1%	-18.2%	HK$201.2m	n/a	PB0.2x	n/a	0%
1672 Ascletis Pharma	HK$1.27	-0.8%	-52.6%	HK$1.3b	HK$2.98	PS21x	E-9.3%	n/a
2256 Abbisko Cayman	HK$3.01	-0.7%	3.8%	HK$1.8b	HK$8.20	PS85.4x	E-2.3%	n/a
6996 Antengene	HK$0.79	-15.1%	-71.5%	HK$533.2m	HK$1.81	PS7.3x	E19.6%	n/a
9966 Alphamab Oncology	HK$4.17	-7.7%	-74.0%	HK$4.0b	HK$4.56	PS17x	E1.6%	n/a
6185 CanSino Biologics	HK$17.50	0.6%	-57.5%	HK$8.2b	HK$26.33	PS11.2x	E124.2%	0%
1548 Genscript Biotech	HK$11.02	-9.4%	-49.3%	HK$23.4b	HK$28.84	PS3.6x	E89.5%	0%

Hong Kong Pharmaceuticals & Biotech Strong Balance Sheet Stocks